Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies
Two part prospective study to:
1. investigate the feasibility of performing ultra-deep sequencing of plasma derived
circulating tumour DNA (ctDNA) in individual patients with advanced solid tumours who are
currently being treated with immune checkpoint inhibitors (ICIs) and
2. obtain fresh tumour biopsies and serial blood samples to investigate the clonal
evolution of tumours under the selection pressure of ICIs.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society